Novanta Set To Replace Six Flax In S&P MidCap 400; Six Flax To Replace Natus Medical In S&P SmallCap 600
$NOVT
$NTUS
$SIX
Industrial Machinery/Components
Miscellaneous
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 5/15/2024 | $29.00 → $27.00 | Buy → Hold | Deutsche Bank | |
| 4/18/2024 | $30.00 → $31.00 | Neutral → Buy | B. Riley Securities | |
| 2/5/2024 | $30.00 | Buy → Neutral | B. Riley Securities | |
| 12/14/2023 | $29.00 → $32.00 | Equal-Weight → Overweight | Morgan Stanley | |
| 11/21/2023 | $32.00 → $25.00 | Buy → Neutral | Rosenblatt | |
| 11/20/2023 | $25.00 → $32.00 | Hold → Buy | Jefferies | |
| 11/3/2023 | $24.00 → $30.00 | Neutral → Buy | B. Riley Securities | |
| 11/3/2023 | $24.00 → $26.00 | Neutral → Buy | Citigroup |
4 - NOVANTA INC (0001076930) (Issuer)
4 - NOVANTA INC (0001076930) (Issuer)
4 - NOVANTA INC (0001076930) (Issuer)
Deutsche Bank downgraded Six Flags from Buy to Hold and set a new price target of $27.00 from $29.00 previously
B. Riley Securities upgraded Six Flags from Neutral to Buy and set a new price target of $31.00 from $30.00 previously
B. Riley Securities downgraded Six Flags from Buy to Neutral and set a new price target of $30.00
144 - NOVANTA INC (0001076930) (Subject)
8-K - NOVANTA INC (0001076930) (Filer)
SCHEDULE 13G/A - NOVANTA INC (0001076930) (Subject)
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter 2025 results on Tuesday, February 24, 2026. The Company will host a conference call on Tuesday, February 24, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Chuck Ravetto, Chief Operating Officer, will be participating at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation wit
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, a
Believes Monetizing Company's Real Estate While Driving Operational Turnaround in Parallel Could Result in Massive Upside to Current Share Price Confident FUN Real Estate Could Attract Multiple Bidders and Sell for Up to $6 Billion; REIT Spin-Out is More Viable Than Ever Given Increased Scale Following Merger with Cedar Fair Views Combination of Real Estate Monetization and Turnaround as Best Pathway to Company Beginning to Trade at Fair Value After Years of Underperformance Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings," "L&B," "us" or "we"), a substantial shareholder of Six Flags Entertainment Corporation (NYSE: FUN) ("Six Flags,
IDEX Corporation (NYSE:IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the company's Board of Directors. The appointments, effective Friday, February 21, 2025, increase the size of the Board from 10 to 12 directors. Ms. Disher will serve on the Board's Nominating and Corporate Governance Committee, and Mr. Glastra will serve on the Board's Audit Committee. Ms. Disher currently serves as Chief Executive Officer of Atmus Filtration Technologies Inc. (NYSE:ATMU), a leader in filtration and media solutions. She has extensive global leadership experience in finance and operations from her time at Atmus, Cummins Inc. and BP, p.l.c. Mr. Glastra currentl
Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter 2025 results on Tuesday, February 24, 2026. The Company will host a conference call on Tuesday, February 24, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the
Third Quarter 2025 GAAP Revenue increased 1.4% to $247.8 million Third Quarter 2025 GAAP Net Income of $10.7 million Third Quarter 2025 GAAP Diluted Earnings Per Share of $0.30 Third Quarter 2025 Adjusted EBITDA of $58.1 million Third Quarter 2025 Adjusted EPS of $0.87 Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) September 26, September 27, 2025 2024 GAAP
Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2025 results on Tuesday, November 4, 2025. The Company will host a conference call on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the ca
SC 13G/A - NOVANTA INC (0001076930) (Subject)
SC 13G - NOVANTA INC (0001076930) (Subject)
SC 13G/A - NOVANTA INC (0001076930) (Subject)